Assessing Stakeholder Opinion on Relations between Cancer Patient Groups and Pharmaceutical Companies in Europe

Author： >  

Publisher： Adis International

ISSN： 1178-1661

Source： The Patient: Patient-Centered Outcomes Research, Vol.5, Iss.2, 2012-06, pp. : 127-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 11, 2015-11 ,pp. : 2384-2391

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug repurposing from the perspective of pharmaceutical companies

By  

BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol. 175, Iss. 2, 2018-01 ,pp. : 168-180

John Wiley & Sons Inc

Access to resources Recommend Favorite

Major Multi-National Pharmaceutical Companies and Complementary Medicine

By  

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 5, Iss. 4, 2004-11 ,pp. : 190-191

Karger

Access to resources Recommend Favorite

Success of ophthalmic pharmaceutical start‐up companies

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 2, 2018-03 ,pp. : e266-e268

John Wiley & Sons Inc

Access to resources Recommend Favorite

Giving voice to cancer patients: assessing non‐specific effects of an integrative oncology therapeutic program via short patient narratives

By  

PSYCHO-ONCOLOGY (ELECTRONIC), Vol. 24, Iss. 2, 2015-02 ,pp. : 169-174

John Wiley & Sons Inc

Access to resources Recommend Favorite